(−)‐Epicatechin induces physiological cardiac growth by activation of the PI3K/Akt pathway in mice

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Molecular Nutrition & Food Research

• Publication date

  2017-02-01

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1002/mnfr.201600343PMID 27605464
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pathophysiology of cardiac hypertrophy and heart failure: signaling pathways and novel therapeutic targets

  2015cited by this paper
• Cell membrane mediated (-)-epicatechin effects on upstream endothelial cell signaling: evidence for a surface receptor.

  2014cited by this paper
• (–)‐Epicatechin improves mitochondrial‐related protein levels and ameliorates oxidative stress in dystrophic δ‐sarcoglycan null mouse striated muscle

  2014cited by this paper
• Regulation of fetal gene expression in heart failure.

  2013cited by this paper
• (–)‐Epicatechin reduces blood pressure and improves vasorelaxation in spontaneously hypertensive rats by NO‐mediated mechanism

  2013cited by this paper
• Diagnostic value of morphometry in feline hypertrophic cardiomyopathy.

  2012cited by this paper
• (-)-Epicatechin-induced calcium independent eNOS activation: roles of HSP90 and AKT

  2012influential reference
• Stimulatory Effects of the Flavanol (-)-Epicatechin on Cardiac Angiogenesis: Additive Effects With Exercise

  2012cited by this paper
• Epicatechin: endothelial function and blood pressure.

  2012cited by this paper
• Contemporary Reviews in Cardiovascular Medicine The Progression of Hypertensive Heart Disease

  2011cited by this paper
• Phosphoinositide-3 kinase signaling in cardiac hypertrophy and heart failure.

  2011cited by this paper
• Contemporary Reviews in Cardiovascular Medicine Athlete's Heart and Cardiovascular Care of the Athlete Scientific and Clinical Update

  2011cited by this paper
• (–)‐Epicatechin enhances fatigue resistance and oxidative capacity in mouse muscle

  2011cited by this paper
• Molecular targets and regulators of cardiac hypertrophy.

  2010cited by this paper
• (−)-Epicatechin Activation of Endothelial Cell Endothelial Nitric Oxide Synthase, Nitric Oxide, and Related Signaling Pathways

  2010influential reference
• Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires Tgf-β.

  2010cited by this paper
• Molecular distinction between physiological and pathological cardiac hypertrophy: experimental findings and therapeutic strategies.

  2010influential reference
• Hypertrophic cardiomyopathy vs athlete's heart.

  2009cited by this paper
• Alteration in left ventricular normal and shear strains evaluated by 2D‐strain echocardiography in the athlete's heart

  2008cited by this paper
• Short- and long-term effects of (-)-epicatechin on myocardial ischemia-reperfusion injury.

  2008cited by this paper
• Molecular regulation of cardiac hypertrophy.

  2008cited by this paper
• Measurement of cardiac function using pressure–volume conductance catheter technique in mice and rats

  2008cited by this paper
• Cardiac plasticity.

  2008influential reference
• Consumption of flavanol-rich cocoa acutely increases microcirculation in human skin

  2007cited by this paper
• Protective effects of exercise and phosphoinositide 3-kinase(p110α) signaling in dilated and hypertrophic cardiomyopathy

  2007cited by this paper
• The emerging role of flavonoid-rich cocoa and chocolate in cardiovascular health and disease.

  2006cited by this paper
• The heart of trained athletes: cardiac remodeling and the risks of sports, including sudden death.

  2006cited by this paper
• Cocoa intake, blood pressure, and cardiovascular mortality: the Zutphen Elderly Study.

  2006cited by this paper
• (-)-Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans.

  2006cited by this paper
• Polyphenols: food sources and bioavailability.

  2004cited by this paper
• Hypertrophy of the heart: a new therapeutic target?

  2004cited by this paper
• Deletion of Ribosomal S6 Kinases Does Not Attenuate Pathological, Physiological, or Insulin-Like Growth Factor 1 Receptor-Phosphoinositide 3-Kinase-Induced Cardiac Hypertrophy

  2004cited by this paper
• Role of Ca2+/calmodulin-dependent protein kinase II in cardiac hypertrophy and heart failure.

  2004cited by this paper
• Athlete’s heart

  2003cited by this paper
• Phosphoinositide 3-kinase(p110α) plays a critical role for the induction of physiological, but not pathological, cardiac hypertrophy

  2003cited by this paper
• Vascular effects of cocoa rich in flavan-3-ols.

  2003cited by this paper
• Heart failure in pressure overload hypertrophy. The relative roles of ventricular remodeling and myocardial dysfunction.

  2002cited by this paper
• The Effect of Fruit and Vegetable Intake on Risk for Coronary Heart Disease

  2001cited by this paper
• Flavonoids: a review of probable mechanisms of action and potential applications.

  2001cited by this paper
• The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms.

  2001cited by this paper
• Left ventricular hypertrophy: pathogenesis, detection, and prognosis.

  2000cited by this paper
• The conserved phosphoinositide 3‐kinase pathway determines heart size in mice

  2000cited by this paper
• The cellular and molecular response of cardiac myocytes to mechanical stress.

  1997cited by this paper
• Flavonoid intake and coronary mortality in Finland: a cohort study

  1996cited by this paper
• Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study.

  1995cited by this paper
• Effects of the Angiotensin Converting Enzyme Inhibitor Enalapril on the Long‐term Progression of Left Ventricular Dilatation in Patients With Asymptomatic Systolic Dysfunction

  1993cited by this paper
• Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study.

  1993cited by this paper
• Prognostic Significance of Serial Changes in Left Ventricular Ejection Fraction in Patients With Congestive Heart Failure

  1993cited by this paper
• Echocardiographic left ventricular hypertrophy: clinical characteristics. The Framingham Heart Study.

  1992cited by this paper
• Identification of alpha- and beta-cardiac myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy.

  1992cited by this paper
• Echocardiographic Left Ventricular Hypertrophy: C1 inical Characteristics.

  1992cited by this paper
• Heart-weight and body-weight in rodents.

  1945cited by this paper

• Effect of Guazuma ulmifolia (Malvaceae) on the metabolic profile of obesity-induced Wistar rats.

  2026cites this paper
• Effects of Epicatechin on the Expression of MyomiRs−31, −133, −136, −206, −296, and −486 in the Skeletal Muscle of the Offspring of Obese Mothers

  2025cites this paper
• Effects of (-)-epicatechin in cardiac hypertrophy of male rats obese by programing

  2025cites this paper
• (−)-Epicatechin treatment modify the expression of genes related to atrophy in gastrocnemius muscle of male rats obese by programing

  2024cites this paper
• Catechins and Proanthocyanidins Involvement in Metabolic Syndrome

  2023cites this paper
• (-)-EPICATECHIN INCREASES APELIN/APLNR EXPRESSION AND MODIFIES PROTEINS INVOLVED IN LIPID METABOLISM OF OFFSPRING DESCENDANTS OF MATERNAL OBESITY.

  2023cites this paper
• Tilianin extracted from Xiangqinglan () inhibits apoptosis induced by mitochondrial pathway and endoplasmic reticulum stress in H9c2 cells after oxygen-glucose deprivation/reoxygenation.

  2023cites this paper
• The AKT Pathway and Satellite Cell Activation in Skeletal Muscle Mass Regulation

  2022cites this paper
• (-) - Epicatechin improves Tibialis anterior muscle repair in CD1 mice with BaCl2-induced damage.

  2022cites this paper
• (-)-Epicatechin Is a Biased Ligand of Apelin Receptor

  2022cites this paper
• The Effect of Diclofenac Sodium on Callus Formation in White Male Rat (Rattus norvegicus) Cruris Fracture Healing

  2022cites this paper
• Interplay between PI3K/AKT pathway and heart disorders

  2022cites this paper
• The Dual Effect and Mechanism of (-)-epicatechin on Hypoxic-induced Proliferation and Apoptosis of Cardiac Fibroblasts

  2021cites this paper
• Curcumol improves cisplatin sensitivity of human gastric cancer cells through inhibiting PI3K/AKT pathway

  2020cites this paper
• Progress in triple negative breast carcinoma pathophysiology: Potential therapeutic targets.

  2020cites this paper
• Advances in physiological functions and mechanisms of (−)-epicatechin

  2020cites this paper
• Metformin Ameliorates Diabetic Cardiomyopathy by Activating the PK2/PKR Pathway

  2020cites this paper
• Recent Research on Flavonoids and their Biomedical applications.

  2020cites this paper
• Protective effect of gastrodin on myocardial ischemia-reperfusion injury and the expression of Bax and Bcl-2

  2019cites this paper
• (-)-Epicatechin reduces adiposity in male offspring of obese rats

  2019cites this paper
• (−)-Epicatechin modifies body composition of the male offspring of obese rats

  2019cites this paper
• (−)-Epicatechin Reduces Blood Pressure and Improves Left Ventricular Function and Compliance in Deoxycorticosterone Acetate-Salt Hypertensive Rats

  2018cites this paper
• Biological activities of (-)-epicatechin and (-)-epicatechin-containing foods: Focus on cardiovascular and neuropsychological health.

  2018cites this paper
• RETRACTED ARTICLE: Alamandine attenuates hypertension and cardiac hypertrophy in hypertensive rats

  2018cites this paper
• (−)-Epicatechin protects against myocardial ischemia-induced cardiac injury via activation of the PTEN/PI3K/AKT pathway

  2018cites this paper
• Aqueous Extract of Davallia mariesii Attenuates 6-Hydroxydopamine-Induced Oxidative Damage and Apoptosis in B35 Cells Through Inhibition of Caspase Cascade and Activation of PI3K/AKT/GSK-3β Pathway

  2018cites this paper
• (-)-Epicatechin inhibits development of dilated cardiomyopathy in δ sarcoglycan null mouse.

  2018cites this paper
• (–)-Epicatechin Suppresses Angiotensin II-induced Cardiac Hypertrophy via the Activation of the SP1/SIRT1 Signaling Pathway

  2017cites this paper